在庫拠点

New Jersey, USA
Czech Republic, EU
Mumbai, India

* 在庫状況によります

Documentation

MSDSをダウンロード

サンプルCOAをダウンロード

内容: HPLC、MASS/LC-MS、1H NMR、FT-IR、含量、構造解析レポート（SER）、および製品に応じた追加分析データ。

1346603-25-5Moxifloxacin Related Compound G

● 在庫あり

カタログ番号:	VL106010
CAS番号:	1346603-25-5
分子式:	C21H25ClFN3O4
分子量:	437.89

見積もり依頼

RFQリストに追加

に関する追加情報 CAS 1346603-25-5

親薬物

Moxifloxacin

IUPAC名

1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aR, 7aR)-octahydro-6H-pyrrolo[3, 4-b]pyridin-6-yl]-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid hydrochloride

同義語

Moxifloxacin HCl (R, R)-Isomer ; (4aR, 7aR)-Moxifloxacin Hydrochloride ;ent-Moxifloxacin Hydrochloride;d-Moxifloxacin Hydrochloride; 1-Cyclopropyl-6-fluoro-1, 4-dihydro-8-methoxy-7-[(4aR, 7aR)-octahydro-6H-pyrrolo[3, 4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Hydrochloride; d-Moxifloxacin Hydrochloride; (4R, 7R)-Moxifloxacin Hydrochloride;

説明

Moxifloxacin Related Compound G (CAS No: 1346603-25-5) or Moxifloxacin HCl (R, R)-Isomer is an impurity present in moxifloxacin that shows antibacterial activity including all major upper and lower respiratory tract pathogens, is one of the most active fluoroquinolones against pneumococci.

References

Kumar, Y. Ravindra., et al. â€œStructural Identification and Characterization of Impurities in Moxifloxacin.â€ Journal of Pharmaceutical and Biomedical Analysis, vol. 34, no. 5, Mar. 2004, pp. 1125â€“29, https://doi.org/10.1016/j.jpba.2003.11.012. Barman Balfour, Julia A., and Harriet M. Lamb. â€œMoxifloxacin.â€ Drugs, vol. 59, no. 1, Jan. 2000, pp. 115â€“39, https://doi.org/10.2165/00003495-200059010-00010.